west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "HOU Ping" 2 results
  • Expression and Correlation of XIAP and Survivin in Primary Hepatocellular Carcinoma

    Objective To investigate the expressions of X-linked inhibitor of apoptosis protein (XIAP) and survivin in primary hepatocellular carcinoma tissues,and to explore the relationship between them. Methods The expressions of XIAP and survivin protein in 38 primary hepatocellular carcinoma tissues and 16 paracancerous tissues were detected by using immunohistochemistry and the expressions were scored. Results The positive expression rate of XIAP and survivin in primary hepatocellular carcinoma tissues was 81.6% (31/38)and 78.9% (30/38),respctively (P<0.001), and in paracancerous tissues was 12.5% (2/16)and 6.3% (1/16), respectively (P<0.001). The score of XIAP expression in the well, middle,and low differentiated tissues of primary hepatocellular carcinoma was (2.91±1.31),(9.27±3.25), and (13.08±2.26) score, respectively (F=118.948,P<0.001), and the score of survivin expression was (4.85±1.83), (11.08±3.72),and (13.38±1.76) score, respectively (F=72.202,P<0.001). They both significantly correlated with the histological grade,but not with the size of tumor(P>0.05). There was significantly correlation between the expression intensity of XIAP and survivin in primary hepatocellular carcinoma tissues (r=0.764, P<0.001). Conclusions The expression intensity of XIAP and survivin in primary hepatocellular carcinoma tissues are both related with the differentiation of primary hepatocellular carcinoma. The expression intensity of XIAP is related with the survivin, and they may play an important role in the tumor progression and chemical resistances.

    Release date:2016-09-08 10:38 Export PDF Favorites Scan
  • Effect of IMPACT management mode on self-care and management abilities of patients with breast cancer undergoing chemotherapy with implantable venous access port

    Objective To observe the effectiveness of IMPACT management mode on self-care and management abilities of breast cancer patients undergoing chemotherapy with implantable venous access port (VAP). Methods Breast cancer patients who underwent chemotherapy with VAP at Shangjin Hospital, West China Hospital, Sichuan University between March 2020 and June 2021 were prospectively included. IMPACT mode was used for self-management training guidance. The patient self-care abilities before training and at 1 month, 2 months, and 3 months of training were compared, and the patient self-management abilities at 1 month and 3 months of training were compared. Results A total of 74 patients with breast cancer undergoing chemotherapy with VAP were included. The total score of self-care ability of patients before training and at 1 month, 2 months, and 3 months of training was 112.11±14.63, 123.20±15.73, 127.95±13.89, and 131.92±13.60, respectively, and all the between-time-point differences were statistically significant (P<0.05). In terms of self-concept score, all the between-time-point differences were statistically significant (P<0.05) with increasing score over time, except the difference between the score at 3 months of training and that at 2 months of training (P>0.05). In terms of self-responsibility and self-care skill scores, all the between-time-point differences were statistically significant (P<0.05) with increasing scores over time, except the difference between the score at 2 months of training and that at 1 month of training (P>0.05). In terms of health knowledge level, the scores at 1 month, 2 months, and 3 months of training were higher than that before training (P<0.05), and the score at 3 months of training was higher than that at 1 month of training (P<0.05). The self-management ability scores in all dimensions at 3 months of training were higher than those at 1 month of training, and the differences were statistically significant (P<0.05). Conclusion The IMPACT management mode can effectively improve the self-care and management abilities of breast cancer patients undergoing chemotherapy with VAP, thereby ensuring the normal use of VAP, reducing the occurrence of complications, and reducing the burden on families and society.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content